arctigenin has been researched along with Hypertension in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, Q; Sun, BC; Xia, WK | 1 |
| Cheng, Y; Wang, Y; Zhou, M | 1 |
| Chen, H; Liu, Y; Sun, C; Wang, G; Yang, M; Yang, S; zhao, Y | 1 |
3 other study(ies) available for arctigenin and Hypertension
| Article | Year |
|---|---|
[Protective effect of arctigenin in GK rats combined with hypertension macroangiopathy].
Topics: Animals; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Models, Animal; Drugs, Chinese Herbal; Furans; Humans; Hypertension; Lignans; Male; Rats; Rats, Wistar | 2015 |
Arctigenin antagonizes mineralocorticoid receptor to inhibit the transcription of Na/K-ATPase.
Topics: Animals; Furans; Gene Expression Regulation; HEK293 Cells; Humans; Hypertension; Lignans; Mineralocorticoid Receptor Antagonists; Receptors, Mineralocorticoid; RNA, Messenger; Sodium-Potassium-Exchanging ATPase; Surface Plasmon Resonance; Transcriptional Activation | 2016 |
Arctigenin reduces blood pressure by modulation of nitric oxide synthase and NADPH oxidase expression in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Furans; Gene Expression Regulation, Enzymologic; Hypertension; Lignans; Male; NADPH Oxidases; Nitric Oxide Synthase; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley | 2015 |